Hema Now | Episode 17
In this episode of Hema Now, host Jonathan Sackier is joined by Paolo Gallipoli, Clinical Reader at the Centre for Haemato-Oncology at Barts Cancer Institute, to break down the biology, onset, and treatment of myeloid leukaemias. They detail common misconceptions about myeloid leukaemias, explain the differences between chronic myeloid leukaemia and acute myeloid leukaemia, and discuss Gallipoli’s own research in the field, with a view towards future developments.
Apple | Amazon Music | YouTube | Download MP3 (35 mins)
Paolo Gallipoli
Paolo Gallipoli is a Clinical Reader at the Centre for Haemato-Oncology at Barts Cancer Institute, Queen Mary University of London, UK. He is additionally an honorary Consultant Hematologist at Saint Bartholomew’s Hospital, Barts Health NHS Trust, UK. His research revolves around the biology and treatment resistance of myeloid leukaemia, focusing on acute myeloid leukaemia.
Timestamps:
01:34 – Quickfire questions
06:55 – Potential careers
08:43 – Common misconceptions
11:34 – Best advice received
13:43 – Adaptive metabolic changes
16:45 – Chronic myeloid leukaemia vs acute myeloid leukaemia
19:20 – Recent publication
22:55 – Clonal hematopoiesis
27:13 – Treatment obstacles
29:18 – Future developments
31:01 – Gallipoli’s three wishes
